| 13/04/22 | 16:44:40 | 13 Apr 2022 | | PRTC's Vedanta Publishes VE303 Data |
| 12/04/22 | 12:05:07 | 12 Apr 2022 | | Akili Depression Data Published in AJP |
| 12/04/22 | 07:00:07 | 12 Apr 2022 | | Glyph: 20x Oral Bioavailability of Buprenorphine |
| 07/04/22 | 07:00:05 | 7 Apr 2022 | | Notice of Results |
| 01/04/22 | 07:00:09 | 1 Apr 2022 | | Total Voting Rights |
| 24/03/22 | 07:00:11 | 24 Mar 2022 | | PRTC Appoints Merck Vet to BOD & Audit Committee |
| 17/03/22 | 13:05:04 | 17 Mar 2022 | | Akili Adds Gaming Vet as Chief Product Officer |
| 16/03/22 | 10:35:01 | 16 Mar 2022 | | Gelesis: Record-Breaking Plenity Prescriptions |
| 08/03/22 | 12:05:08 | 8 Mar 2022 | | Akili Named to World's Most Innovative Companies |
| 18/02/22 | 16:30:05 | 18 Feb 2022 | | Holding(s) in Company |
| 17/02/22 | 12:05:04 | 17 Feb 2022 | | Akili Data: Enhanced Brain Activity in Kids w/ADHD |
| 15/02/22 | 07:00:06 | 15 Feb 2022 | | PRTC's Akili Files Registration Statement on S-4 |
| 10/02/22 | 12:00:01 | 10 Feb 2022 | | PRTC to Present at Leerink Healthcare Conference |
| 04/02/22 | 07:00:04 | 4 Feb 2022 | | PDMR DEALING - PURCHASE OF SHARES |
| 31/01/22 | 11:50:02 | 31 Jan 2022 | | PRTC's Gelesis Launches Plenity Media Campaign |
| 26/01/22 | 12:02:09 | 26 Jan 2022 | | PRTC’s Akili to Become Public & $162M Funding |
| 14/01/22 | 07:00:05 | 14 Jan 2022 | | PRTC's Gelesis to Debut on NYSE Today Ticker GLS |
| 07/01/22 | 12:00:02 | 7 Jan 2022 | | PureTech to Present at JPM Healthcare Conference |
| 06/01/22 | 07:00:06 | 6 Jan 2022 | | LYT-100 Shows Improved AE Profile vs Pirfenidone |
| 05/01/22 | 12:05:08 | 5 Jan 2022 | | Gelesis Adds to BOD & Declared Effective by SEC |
| 20/12/21 | 07:00:07 | 20 Dec 2021 | | PDMR DEALING - PURCHASE OF SHARES |
| 16/12/21 | 07:00:08 | 16 Dec 2021 | | PRTC Provides Recap Ahead of Catalyst-Rich 2022 |
| 08/12/21 | 12:00:03 | 8 Dec 2021 | | PRTC Presents Data at ACNP Conference For LYT-300 |
| 07/12/21 | 12:00:09 | 7 Dec 2021 | | PRTC's Lymphatic Platform Candidate Human Study |
| 01/12/21 | 12:10:05 | 1 Dec 2021 | | PRTC: Gelesis' Plenity Now Broadly Available in US |
| 01/12/21 | 07:00:09 | 1 Dec 2021 | | Total Voting Rights |
| 18/11/21 | 12:10:01 | 18 Nov 2021 | | PRTC's Gelesis Receives $30M Plenity Order from Ro |
| 16/11/21 | 12:00:01 | 16 Nov 2021 | | PRTC Publishes Previous LYT-100 MAD Study Results |
| 15/11/21 | 12:00:04 | 15 Nov 2021 | | PRTC Presents at Two Upcoming Investor Conferences |
| 12/11/21 | 12:00:03 | 12 Nov 2021 | | PRTC Presents Immunooncology Ph 1/2 Trial at SITC |
| 11/11/21 | 12:00:00 | 11 Nov 2021 | | FDA Grants PRTC's LYT-200 Orphan Drug Designation |
| 10/11/21 | 07:00:05 | 10 Nov 2021 | | PRTC Receives $100M from Founded Entity Shares |
| 09/11/21 | 12:34:19 | 9 Nov 2021 | | KRTX and Zai Lab to Develop KarXT in Greater China |
| 09/11/21 | 07:00:03 | 9 Nov 2021 | | PRTC Presents at Jefferies Healthcare Conference |
| 01/11/21 | 10:20:01 | 1 Nov 2021 | | New Research in Journal Nature on Gelesis Tech |
| 01/11/21 | 07:00:10 | 1 Nov 2021 | | Total Voting Rights |
| 22/10/21 | 18:00:07 | 22 Oct 2021 | | Holdings in Company - TR-1 Correction Announcement |
| 20/10/21 | 16:35:55 | 20 Oct 2021 | | Price Monitoring Extension |
| 14/10/21 | 12:01:01 | 14 Oct 2021 | | PRTC's Vedanta Appoints Chief Legal Officer |
| 12/10/21 | 07:00:05 | 12 Oct 2021 | | Additional Listing |
| 05/10/21 | 13:01:07 | 5 Oct 2021 | | Vedanta Positive Phase 2 Data in C. Diff Infection |
| 05/10/21 | 13:00:04 | 5 Oct 2021 | | PRTC's Sonde Launches Mental Health Monitor |
| 29/09/21 | 13:01:05 | 29 Sept 2021 | | Akili/Shionogi Report Positive Ph2 Data in Japan |
| 20/09/21 | 16:02:37 | 20 Sept 2021 | | New PureTech Research Published In Nature Journal |
| 14/09/21 | 12:00:01 | 14 Sept 2021 | | PRTC to Present at Oppenheimer Healthcare Summit |
| 10/09/21 | 07:00:06 | 10 Sept 2021 | | PRTC's Vor Granted FDA Fast Track Designation |
| 01/09/21 | 07:00:06 | 1 Sept 2021 | | Total Voting Rights |
| 24/08/21 | 07:00:04 | 24 Aug 2021 | | Half-year Report |
| 23/08/21 | 12:00:02 | 23 Aug 2021 | | PRTC Presents LYT-100 Ph1 PK & Tolerability at ERS |
| 17/08/21 | 13:03:01 | 17 Aug 2021 | | Akili Deal Furthers Digital Medicine Leadership |
